EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel

 
• By Neena Brizmohun

Radius’s abaloparatide, which was previously rejected by the European Medicine Agency, is among the latest products that are this week being considered for EU-wide marketing approval by the agency.

Pills or capsules as a question mark and white plastic bottle.
The EMA is deciding whether to recommend EU marketing approval for new drugs • Source: Alamy

More from Europe

More from Geography